Pluristem Therapeutics, Inc. Competitors

PSTI 
$2.46
*  
unch
unch
Get PSTI Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading PSTI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Pluristem Therapeutics, Inc.
CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Biogen Idec Inc.
BIIB: NASDAQ-GS
$ 340.885 5.13 ▲ 966,287 $ 343.62
$ 334.98
$ 361.93
$ 270.62
32.25 80,501,697,175
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 88.76 3.23 ▲ 417,541 $ 90.87
$ 85.5457
$ 94.4899
$ 17.40
NE 2,558,329,480
Amgen Inc.
AMGN: NASDAQ-GS
$ 160.67 3.15 ▲ 2,222,853 $ 163.17
$ 156.4705
$ 173.14
$ 108.20
25.3 122,216,848,900
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 91.29 1.84 ▲ 21,205,192 $ 92.67
$ 88.86
$ 116.83
$ 63.50
16.1 137,725,936,560
Aerie Pharmaceuticals, Inc.
AERI: NASDAQ-GM
$ 29.49 1.23 ▲ 54,043 $ 29.75
$ 28.40
$ 32.50
$ 13.66
NE 707,288,160
NPS Pharmaceuticals, Inc.
NPSP: NASDAQ-GS
$ 35.06 1.18 ▲ 385,038 $ 35.22
$ 34.0652
$ 39.68
$ 22.11
3506 3,745,810,400
Bio-Techne Corp
TECH: NASDAQ-GS
$ 94.41 1.16 ▲ 71,940 $ 94.58
$ 92.835
$ 97.15
$ 82.51
32.67 3,500,345,160
Celladon Corporation
CLDN: NASDAQ-GM
$ 18.54 0.85 ▲ 64,299 $ 18.76
$ 17.655
$ 19.4826
$ 7.45
NE 432,074,700
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 38.80 0.80 ▲ 124,767 $ 39.26
$ 37.91
$ 57.89
$ 23.61
NE 1,251,416,400
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 14.85 0.79 ▲ 102,972 $ 15.1375
$ 13.84
$ 16.25
$ 12.27
NE 493,881,300
BioCryst Pharmaceuticals, Inc.
BCRX: NASDAQ-GS
$ 11.83 0.76 ▲ 811,275 $ 11.89
$ 11.09
$ 14.62
$ 7
NE 850,151,120
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 39.14 0.74 ▲ 183,377 $ 39.83
$ 38.18
$ 40.75
$ 27.51
69.89 1,641,844,720
DBV Technologies S.A.
DBVT: NASDAQ-GS
$ 26.81 0.66 ▲ 27,998 $ 26.87
$ 26.45
$ 28.50
$ 22.20
NE 989,020,900
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 51.96 0.45 ▲ 231,833 $ 52.9599
$ 51.49
$ 57.87
$ 21
NE 1,992,614,040
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 28 0.41 ▲ 8,469 $ 28.5053
$ 27.36
$ 35.45
$ 9.66
NE 565,964,000
Repligen Corporation
RGEN: NASDAQ-GS
$ 19.84 0.39 ▲ 201,148 $ 20.11
$ 19.1492
$ 26.75
$ 11.70
55.11 649,204,480
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 9.34 0.31 ▲ 866,949 $ 9.60
$ 9.1399
$ 18.18
$ 6.88
NE 1,171,114,580
Heska Corporation
HSKA: NASDAQ-CM
$ 18.13 0.24 ▲ 66,763 $ 18.63
$ 17.89
$ 18.06
$ 8.041
37.77 114,581,600
Repros Therapeutics Inc.
RPRX: NASDAQ-CM
$ 8.88 0.24 ▲ 278,374 $ 9.10
$ 8.60
$ 22.57
$ 5.915
NE 215,570,880
Fate Therapeutics, Inc.
FATE: NASDAQ-GM
$ 4.902 0.23 ▲ 3,920 $ 4.9999
$ 4.73
$ 13.55
$ 3.50
NE 100,829,238
Applied Genetic Technologies Corporation
AGTC: NASDAQ-GM
$ 20.96 0.22 ▲ 42,366 $ 21.24
$ 20.61
$ 34.37
$ 11.10
NE 343,974,560
Brainstorm Cell Therapeutics Inc.
BCLI: NASDAQ-CM
$ 3.85 0.22 ▲ 265,105 $ 3.90
$ 3.61
$ 5.7001
$ 2.025
NE 58,831,850
Novavax, Inc.
NVAX: NASDAQ-GS
$ 5.81 0.18 ▲ 949,284 $ 5.86
$ 5.64
$ 6.95
$ 3.34
NE 1,385,557,180
Proteon Therapeutics, Inc.
PRTO: NASDAQ-GM
$ 10.40 0.17 ▲ 1,022 $ 10.42
$ 10.40
$ 12
$ 8.57
NE 171,069,600
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 6.81 0.15 ▲ 2,807,829 $ 6.85
$ 6.60
$ 9.83
$ 4.90
NE 1,274,913,720